News
09.11.2023

ADDITIONAL MEASLES VACCINE HAS BEEN PURCHASED

In Kazakhstan, urgent response measures have been taken to stabilize the epidemiological situation regarding measles incidence. In order to prevent the further spread of measles among the population, the chief state sanitary doctor signed a decree on conducting additional mass immunization against measles, rubella and mumps.

Thus, on November 6, additional mass immunization against measles, rubella and mumps began for children, regardless of measles vaccination status.

The single distributor, on behalf of the Ministry of Health of the Republic of Kazakhstan, has worked out the purchase of an additional volume of vaccine for immunization of the population. Thus, at the request of the regional health departments, an additional volume of vaccine against measles, rubella and mumps was purchased in the amount of 503,000 doses.

In addition, it is planned to purchase more than 1 million doses of the vaccine, financing of which will be provided from the reserve of the Government of the Republic of Kazakhstan.

Transportation of vaccines is carried out according to the “cold chain” principle - at each stage, strict temperature control is ensured. When transporting vaccines, registration of receipt and further departure is carried out, with temperature readings recorded in the accompanying documents.

For reference:

The measles, mumps, rubella vaccine is a combination vaccine that helps protect against three serious viral diseases. The vaccine contains live but weakened measles, mumps and rubella viruses.

Source: Press service of SK-Pharmacy LLP"
1439
Contact center
Free of charge for all numbers
Подробнее
Public control
Acting Chairman's blog
Video
Photo gallery
PROSPECTS FOR THE DEVELOPMENT OF THE DOMESTIC PHARMACEUTICAL INDUSTRY
Подробнее
G2B AND B2B MEETINGS - NEW OPPORTUNITIES FOR THE DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY OF KAZAKHSTAN
Подробнее
Форум
Подробнее
Посмотреть еще
22 июня 2024
Источник: Пресс-служба ТОО "СК-Фармация"
18 июня 2024
Источник: Пресс-служба ТОО "СК-Фармация"
14 июня 2024
Источник: Пресс-служба ТОО "СК-Фармация"